70results about How to "Reduce bowel movements" patented technology

The invention is a Chinese traditional medicine compound for treating intestines functions disorder. The compound includes following ingredients: bupleurum root 6-18g, white peony root 6-30g, pseudostellaria root 3-18g, liquorice 6-15g. The method can be used in clinic directly without adding ingredients; it also can use the extract of above mentioned medicines as medicine; the extract is: a. extract the volatile oil for backup from above mentioned compound; b. carries on extraction with water, alcohol, or other organic solution to above mentioned volatile oil compound; c. purifies and separates: water extracting liquid, vacuum condensing, and alcohol depositing, resin absorbing and exchanging, high speed eccentric process, and cyclodextrin packaging method; d. the extracts in above steps are combined, and become medicine compound. There also can increase lagehead atractylodes, chuaniong rhizome, Tuckahoe, kudzu vine root, uncaria and other medicines; or some compounds such as shimida, and dopan ketone. The invention also provides a manufacturing method for above mentioned medicine.

The invention discloses a lactobacillus fermentum Lee working fermenting agent product and application thereof to prevent constipation and keep healthy. Lactobacillus fermentum Lee is preserved in China Center for Type Culture Collection with the preservation number of CCTCCM2013512. Lactobacillus fermentum Lee is capable of normally growing in human intestinal tracts. Mouse in-vivo tests show that lactobacillus fermentum Lee is capable of alleviating the mouse body weight mitigating trend caused by constipation, accelerating melaena discharging time, improving intestinal propulsive rate, increasing levels of MTL, Gas, ET, AchE, SP and VIP in serum to different degrees, reducing SS factor level, increasing food intake and water intake, and reducing the decrease trend of defecation amount, defecation particle quantity and water content in faeces, gives play to effects similar to that of constipation-treating medicines, and shows certain constipation prevention effect. The optimum usage dosage is 1.0*10<9> CFU for per kg body weight.

The invention discloses Lactobacillus fermentum suo for adjusting intestinal tract motion and preventing constipation and a use thereof. The Lactobacillus fermentum suo has a preservation number of CCTCC NO: M2013511, has strong acid resistance, has a survival rate of 92.46+ / -4.06% after being arranged in an artificial gastric juice with a pH value of 3.0 for 3h, can slowly grow in cholate with a concentration of 1.0%, has a growth rate 17.36+ / -1.19% that of cholate-free culture, has cell hydrophobicity of 68.44+ / -2.48% and can normally grow in the human intestinal tract. Lactobacillus fermentum suo can relieve constipation-caused mouse weight reduction, reduce tarry stool excretion time, improve a small intestine propulsion rate, improve serum MTL, Gas, ET, AchE, SP and VIP factor levels to different degrees, reduce a SS factor, improve food intake and water intake, relieve reduction of a stool excretion mount, the number of stool particles and stool water content and can produce a certain constipation prevention effect similar to those of constipation treatment drugs.

The invention discloses Lactobacillus fermentum zhao capable of regulating intestinal movement and preventing constipation and application thereof, wherein the preservation number of the Lactobacillus fermentum zhao is CCTCCM2013513. The strain has higher acid resistance, has a survival rate reaching 85.12% plus / minus 5.18% after staying in pH3.0 artificial gastric juice for 3 h, can grow slowly in cholate with the concentration of 1.0% and has a growth efficiency reaching 18.33% plus / minus 0.52% of that of cholate-free culture. The hydrophobicity of Lactobacillus fermentum zhao cells is up to 70.80% plus / minus 0.61%. The Lactobacillus fermentum zhao can grow normally in human intestinal tracts. In-vivo tests using mice show that the Lactobacillus fermentum zhao can reduce the weight reduction tendency of the mice, shorten the time of defecation of dark stool, improve the peristalsis of small intestines, increase MTL, Gas, ET, AchE, SP and VIP factors to different extents, reduce SS factors, increase food consumption and water consumption, reduce the tendency that stool amount, stool pieces and stool water content decline, play an effect similar to that of a constipation medicine and show a certain constipation prevention effect.

The invention discloses a lactobacillus fermentum Lee working leavening agent product and constipation-prevention and health application thereof. The preservation number of lactobacillus fermentum Lee in China Center for Type Culture Collection is CCTCCM 2013512. The lactobacillus fermentum Lee can normally grow in intestinal tracts of human bodies. A mouse in vivo test further shows that the lactobacillus fermentum Lee can be used for retarding a mouse weight-reducing tendency caused by constipation; melena defecation time is accelerated and the small intestine propelling rate is improved; levels of MTL, Gas, ET, AchE, SP and VIP factors of blood serum can be increased to different extents, and SS factors are reduced; the food intake and the water drinking amount are increased; the tendency that defecation amount, the defecation grain quantity, and the moisture content of excrement decline are reduced; and the effect similar with constipation drugs is realized and a certain constipation-prevention effect is represented. The optimal use dosage is 1.0*10<9>CFU per kilogram of weight.

The invention discloses oral administration of a traditional Chinese medicine composition for treating irritable bowel syndrome, belonging to traditional Chinese medicine art. The oral traditional Chinese medicine composition for treating irritable bowel syndrome has drug materials as active ingredients with the following weight ratios (wt.%): 15 radix codonopsitis, 18 radix paeoniae alba, 20 Chinese yam rhizome, 25 coat of hyacinth bean, 15 poria, 10 shizandra berry, 10 radix bupleuri, 10 cabline patchouli, 10 medicated leaven, 15 Chinese atractylodes, 9 dried orange peel, 10 radix sileris, and 10 toasted rhizoma atractylodis alba. The composition is taken by herbal decoction. After combining the above drugs in the invention, the composition has synergistic reactions of strengthening spleen and warming zhong, removing dampness and guiding stagnancy, and harmonizing intestine-stomach. The oral traditional Chinese medicine composition has remarkable effect for treating the irritable bowel syndrome with reliable curative effect and no toxic and side effect.

The invention discloses a tibetan medicament for treating constipation and a preparation method thereof. The tibetan medicament consists of active components or active components and pharmaceutically acceptable auxiliaries, wherein the active components are prepared from whim, purpurea halitium, cassiae fructus, tronae and rheum officinale in a certain weight ratio. The tibetan medicament can be produced into an arbitrary common internal preparation, has the functions of clearing heat accumulation, and breaking stasis and eliminating mass, and can be used for treating gastrointestinal accumulated masses, constipation, belch and abdominal pain, gastrointestinal function degradation and other symptoms. The tibetan medicament can be used in constipation with remarkably reduced defection times caused by internal heat and qi depression (every 2-3 days or even longer period per time), irregular constipation, hard excrement and the like.

The invention discloses a lactobacillus casei strain Qian (CCTCC No. M2013514) working leavening agent product and an intestinal tract regulating health use thereof. The lactobacillus casei strain Qian working leavening agent product and a downstream product thereof are relatively strong in acid resistance, are 62.51+ / -7.35% in survival rate after being treated for 3 hours in artificial gastric juice with pH of 3.0, and are capable of slowly growing in 1.0% cholate, wherein the growth efficiency is 7.86+ / -0.45% that in non-cholate cultivation; the hydrophobic property of lactobacillus casei strain Qian cells is up to 51.30+ / -4.28%, and the lactobacillus casei strain Qian working leavening agent product normally grows in human intestinal tract. The lactobacillus casei strain Qian working leavening agent product can be used for slowing down mouse weight reducing trend caused by constipation, shortening dark stool defecating time, increasing a small intestine advance rate, reducing the gene expression level of mouse TRPV1. NOS, reducing the defecation quantity, and reducing defecation granule number and excrement moisture content reducing trend, achieves similar effects of constipation drugs and shows a certain constipation prevention effect.

The invention discloses chickpea powder for treating diarrhea and a method for preparing the same. The chickpea powder is prepared from a chickpea powder material, banana extract, red bayberry extract, phoenix-tail fern, plantain, raspberry root, and root of marie sophora. Primary grinding and superfine grinding are carried out on the chickpea powder material, the phoenix-tail fern, the plantain, the raspberry root, and the root of marie sophora to prepare a superfine powder material; bananas and red bayberries are immersed into water and then the immersed bananas and red bayberries are decocted; ethyl alcohol is used for extraction, the chickpea powder material is added and uniform mixing is carried out, heating is carried out to prepare a fluid extract, and drying and grinding are carried out to obtain superfine powder; and then the superfine powder materials are mixed, thereby obtaining chickpea powder for treating diarrhea. According to the chickpea powder disclosed by the invention, the raw materials of the chickpea powder supplement each other to realize a good antidiarrheal effect. Meanwhile, the chickpea powder has effects of regulating the blood fat and blood glucose, clearing heat and promoting dieresis, moistening lung and clearing away toxic materials. Because of no additive agent, no side effect on the human body is caused.

The invention relates to a traditional Chinese medicine combination for treating infantile diarrhea and a preparation method thereof. Raw material medicine of the traditional Chinese medicine combination is composed of 5-15 parts of ginseng, 5-19 parts of Chinese yam, 8-16 parts of fig roots, 7-18 parts of pittosporm roots, 10-20 parts of Chinese dates, 2-10 parts of fried endothelium corneum gigeriae galli, 5-14 parts of amomum, 2-8 parts of red halloysite, 5-14 parts of emilia sonchifolia, 10-20 parts of roasted malt, 5-18 parts of poria cocos, 5-18 parts of dried tangerine or orange peel, 8-20 parts of hawthorns, 5-15 parts of plantain and 5-20 parts of yam. A good curative effect is obtained when oral liquid or granules are taken three times, the effect is obvious when the traditional Chinese medicine combination is taken for two days, the defection frequency is remarkably reduced, the food intake amount of a child is increased when the traditional Chinese medicine combination is continuously taken for 7 days, the mental state of the child is good, the infantile diarrhea is basically cured, and the effective rate is 100%. Compared with the prior art, the pure traditional Chinese medicine is adopted for preparing the traditional Chinese medicine combination, the infantile diarrhea can be effectively treated and is not prone to relapse, and toxic and side effects are avoided; the traditional Chinese medicine low in price is adopted, and environmental protection is facilitated. The preparation technology of traditional Chinese medicine combination is simple, and the traditional Chinese medicine combination can be industrially produced.

The invention discloses a medicine used for treating chronic enteritis, which belongs to a field of traditional Chinese medicine.The medicine for treating chronic enteritis is formulated by dangshen, atractylodes macrocephala, povia, chiretta, Szechwan lovage rhizome, red peony root, rhizoma corydalis, cyathula root, salvia root, dioscorea root, cornus dogwood fruit and cassia bark by certain weight. The crude drug is put into an earthenware pot and is soaked by adding proper water; the earthenware pot is firstly decocted to boil by strong fire, and then decocted by aoft fire for half an hour. The liquid medicine is filtered, and proper water is added into dregs and decocted for half an hour; then the medicine liquid is filtered again. Liquid medicine obtained from the two steps is mixed together and cooled. The medicine is taken half an hour before breakfast and two hours after supper respectively.By taking the medicine for half a month, the medicine can clear heat and toxic material, promote digestion, remove food retention and flatulence, alleviate pain, harmonize intestine-stomach, elevate the spleen yang, eliminate dampness and tonify spleen for nourishing qi. By taking the medicine for a month, gastrointestinal disfunction is improved, regeneration and repair of intestinal mucosa is promoted and overall immunity is enhanced, which achieves the goal of complete cure. The invention treat 120 cases all together with a efficient rate of 100 percent and a recovery rate of 99 percent.

The invention relates to a method for producing a feed additive, in particular to the method for producing the feed additive by utilizing the fermentation of waste vinasse, which belongs to the technical field of feed processing. The method comprises the steps of strain culture, heating sterilization treatment, solid mixing fermentation, drying and production finishing, and the like. The waste vinasse is converted into the feed additive for livestock and poultry by microbial fermentation so as to effectively increase the utilization rate of feeds and reduce the excreta of the livestock and the poultry, and can be used partially or totally instead of antibiotics so as to solve the problem of harmful substance residues in livestock and poultry meat.

The invention discloses an oral administration pharmaceutical composition for treating irritable bowel syndrome, wherein the active constituents include the following raw material herbs (by weight portion): campanumaea pilosula 15, chicken's gizzard-skin 10, goldthread root 3, astragalus root 8, honey-fried licorice root 6, poria cocos wolf 15, plantain seeds 8, banksia rose 6, dahurian angelica root 6, wrinkled giant-hyssop 10, root of herbaceous peony 10, haw 10 and dried orange peel 9. The medicament should be decocted in water for the oral dose.

The invention discloses a compound medicine for treating gastrointestinal tract tumors. The medicine is prepared from the following traditional Chinese medicinal raw materials in parts by weight: 3-5 parts of radix ranunculi ternati, 4-6 parts of fructus polygoni orientalis, 3-5 parts of myrrh, 3-5 parts of rabdosia rubescens, 3-5 parts of indigo naturalis, 5-8 parts of radix sophorae tonkinensis, 2-4 parts of platycodon grandiflorum, 2-4 parts of moutan bark, 6-10 parts of astragalus membranaceus, 6-8 parts of radix pseudostellariae, 1-3 parts of lucid ganoderma, 5-8 parts of donkey-hide gelatin, 8-10 parts of cortex albiziae, 2-5 parts of selfheal, 2-4 parts of radix scutellariae, 2-4 parts of cortex phellodendri, 2-4 parts of fructus forsythiae, 2-4 parts of dandelion, 2-5 parts of pleione bulbocodioides, 3-5 parts of dahurian patrinia herb, 2-3 parts of allium macrostemon, 5-8 parts of circium japonicum, 3-5 parts of seaweed and 3-5 parts of kelp. According to the traditional Chinese medical theory of strengthening and consolidating body resistance and promoting blood circulation to remove stasis, the compound medicine has the effects of tonifying liver and kidney, tonifying qi, nourishing yin, clearing heat, removing toxicity, eliminating and diminishing swelling and treating gastrointestinal tract tumors, can be used for treating both symptoms and root causes, and has the advantages of good curative effect and quick response.

The invention discloses a lactobacillus casei strain Qian working stock culture product and an intestinal tract regulation dietary therapy funtion thereof. The lactobacillus casei strain Qian working stock culture product and downstream products thereof are stronger in acid-resistance, after being processed in artificial gastric juice of PH 3.0 for 3 hours, the survival rate of the products reaches 62.51+ / -7.35%, can grow slowly in 1.0% cholate with the production efficiency being 7.86+ / -0.45% of no cholate culture, hydrophobicity of lactobacillus casei strain Qian cells reaches 51.30+ / -4.28%, and the lactobacillus casei strain Qian cells can grow normally in the intestinal tract of human beings; the weight losing tendency of mice caused by constipation can be alleviated, the dark stool defecating time is shortened, the small intestine advance rate is improved, the TRRV1,NOS gene expression level of mice is lowered, and the tendency that defecating amount, the defecating particles and faeces water content are decreased is lowered, so that the lactobacillus casei strain Qian working stock culture product has the function similar to that of constipation medicine, and shows certain constipation prevention effect.

The invention discloses an oral administration Chinese medicinal composition for treating irritable bowel syndrome, wherein the active constituents include the following raw material herbs (by weight portion): campanumaea pilosula 15g, chicken's gizzard-skin 10g, coptis root 3g, astragalus root 10g, honey-fried licorice root 6g, plantain seed 10g, banksia rose 6g, dahurian angelica root 6g, wrinkled giant-hyssop 8g, haw thorn charcoal 8g and dried orange peel 6g. The medicament should be decocted in water for the oral dose.

A Chinese medicine 'Chunyang Zhengqi' capsule based on 'Chunyang Zhengqi' pill for treating acute enterogastritis is prepared from cablin pachouli, pinellia tuber, etc.

The invention discloses a compound fig preparation, which comprises fig extract, chitosan and pharmaceutically acceptable accessories or excipient, wherein the weight ratio of the fig extract to the chitosan is (1:4)-(9:1). The compound preparation is any oral preparation of tablets, capsules, pills and oral liquid. The fig extract and the chitosan are compounded and prepared into a compound by the modern pharmaceutical preparation technology to treat diarrhea and constipation. The effective components of the fig are extracted, so compared with taking the whole grain of fig, the compound preparation discards other components without treatment functions in the fig, and has good effect and has no side effect. The compound preparation has the advantages of low cost, good effect, and the like.

The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine formula for treating ulcerative colitis. The traditional Chinese medicine in the formula comprises the following traditional Chinese medicine raw materials in parts by weight: 15-20 parts of codonopsis pilosula, 15-20 parts of astragalus membranaceus, 15-20 parts of Chinese yam, 15-20 parts of fructus psoraleae, 15-20 parts of semen cuscutae, 5-10 parts of fructus alpiniae oxyphyllae, 20-25 parts of schisandra chinensis, 10-15 parts of dendrobe, 10-20 parts of rhodiola rosea, 15-20 parts of cortex ailanthic, 15-20 parts of lotus seeds, 15-20 parts of euryale ferox, 5-10 parts of sargent gloryvine, 5-10 parts of patrinia, 5-15 parts of cherokee rose fruit, 5-10 parts of burdock and 8-12 parts of limonite. Due to conditioning of the traditional Chinese medicines, the traditional Chinese medicine in the formula has the effects of invigorating spleen and regulating the middle warmer, tonifying intestines, adjusting yin and yang, tonifying visceral-qi, clearing heat and drying damp, removing carbuncle and discharging pus as well as removing necrotic tissue and relieving pain, can be used for treating ulcerative colitis, can prompt anabrosis healing, is gentle in medicine property and small in side effect, and can both treat the symptoms and the root causes.

The invention discloses a lactobacillus fermentum Lee working leavening agent product and constipation-prevention and health application thereof. The preservation number of lactobacillus fermentum Lee in China Center for Type Culture Collection is CCTCCM 2013512. The lactobacillus fermentum Lee can normally grow in intestinal tracts of human bodies. A mouse in vivo test further shows that the lactobacillus fermentum Lee can be used for retarding a mouse weight-reducing tendency caused by constipation; melena defecation time is accelerated and the small intestine propelling rate is improved; levels of MTL, Gas, ET, AchE, SP and VIP factors of blood serum can be increased to different extents, and SS factors are reduced; the food intake and the water drinking amount are increased; the tendency that defecation amount, the defecation grain quantity, and the moisture content of excrement decline are reduced; and the effect similar with constipation drugs is realized and a certain constipation-prevention effect is represented. The optimal use dosage is 1.0*10<9>CFU per kilogram of weight.

The invention relates to the technical field of formula milk powder, in particular to infant formula milk powder rich in structural fat OPL and a preparation method of the infant formula milk powder. The infant formula milk powder is blended by taking raw milk as a main raw material and adding mixed grease rich in structural fat OPL and other ingredients; the mixed grease rich in the structural fat OPL is blended from structural fat OPL with the mass fraction of 54-58% and palmitic acid at the sn-2 position larger than 80% and mixed vegetable oil; and the structural fat OPL in the infant formula milk powder accounts for 6-15% of the mass of triglyceride in the milk powder. The infant formula milk powder is processed by a wet method, raw milk is taken as raw milk, pre-sterilization is performed after the milk is purified, mixed grease rich in OPL structural fat and other ingredients are added into the pre-sterilized raw milk, sterilization is performed after homogenization, and the infant formula milk powder is obtained through concentration and spray drying. The infant formula milk powder disclosed by the invention has the effects of reducing constipation and difficult defecation of infants, perfecting absorption and utilization of fat energy and promoting growth and development of bones of the infants.

The present invention provides a powder pharmaceutical formulations for treating infantile diarrhea which overcomes weak pocket of other medicament for treating the disease. The powder pharmaceutical formulation is prepared by raw materials as follows: biofermin 0.1-1 g, compound diphenoxylate 0.25-2.5 mg, acetylsalicylic acid 0.3-0.15 g, chlorphenamine 0.04-0.2 mg and hydrochlorothiazidum tablet 1-5 mg, the above medicine are grinded to dead small, then are measured and packed for obtaining the powder pharmaceutical formulation. The powder pharmaceutical formulation for treating infantile diarrhea is used about twenty years and is consulted by patients 10000 times, wherein, males 5500 times, females 4500 times, curative rate 98% and efficiency rate 100%.

The invention discloses a Lactobacillus fermentum strain Zhao which can regulate intestinal motility and prevent constipation. The preservation number is CCTCC NO: M 2013513 and its application. After 3 hours in gastric juice, the survival rate reached 85.12±5.18%. It can grow slowly under 1.0% concentration of bile salt, and the growth efficiency reaches 18.33±0.52 of culture without bile salt. The hydrophobicity of Lactobacillus fermentum strain Zhao cells also reached 70.80±0.61 %. Can grow normally in the human intestine. Experiments in mice also showed that Lactobacillus fermentum strain Zhao can slow down the weight loss trend of mice caused by constipation, accelerate the time of black stool discharge, improve the propulsion rate of the small intestine, and increase serum MTL, Gas, ET, The levels of AchE, SP and VIP factors, decreased SS factors, increased food intake and water intake, decreased defecation volume, the number of defecated particles and the trend of decreasing water content in feces, played a similar role to constipation drugs, showing a certain preventive effect on constipation .

The invention discloses a dendrobium officinale mixture. The dendrobium officinale mixture is prepared from the following traditional Chinese medicinal materials serving as raw materials in parts by weight: 10 to 12 parts of dendrobium officinale, 15 to 25 parts of raw atractylodis macrocephalae rhizome, 10 to 20 parts of radix scrophulariae, 10 to 20 parts of radix ophiopogonis, and 10 to 20 parts of raw radix rehmanniae. The dendrobium officinale mixture has the effects of increasing fluid, moistening dryness, nourishing yin, clearing heat, strengthening spleen and tonifying qi, and is used for constipation and the diseases that the defecating frequency is reduced, the excrement amount is little and hard in texture, a pleasant feeling disappears after defecating, and the defecating time or the defecating interval time is prolonged. In order to prove a good effect of the dendrobium officinale mixture to the constipation better, the effect of the mixture to a mouse with the constipation induced by compound diphenoxylate is investigated through an animal experiment; the effect shows that the mixture can promote the pushing of small intestines of the mouse with the constipation, promote defecation, protect intestinal mucosa and improve serum SOD.

The invention relates to a method for producing a goldfish feed from bagasse. The goldfish feed contains bagasse, corn flour, bean pulp, bran, sweet potato powder, shrimp meal, bone meal and caulis spatholobi. According to the method producing the goldfish feed from bagasse, the bagasse of a sugar refinery is adequately utilized, so that the treatment cost of the bagasse of the sugar refinery is lowered, and the environmental pollution caused by caulis spatholobi is reduced; on the other hand, the nutrients in the bagasse of the sugar refinery are adequately utilized, so that the preparation cost of the goldfish feed is lowered; by adding caulis spatholobi, the defecation quantity of the goldfishes can be substantially reduced, and the ornamental value of the goldfishes is improved; and the preparation process is simple, and the preparation cost is low.

The invention discloses a compound medicine for treating gastroenteric tumor. The compound medicine is prepared from the following traditional Chinese medicinal raw materials in parts by weight: 3 to 5 parts of radix ranunculi ternate, 4 to 6 parts of fructus polygoni orientalis, 3 to 5 parts of myrrh, 3 to 5 parts of herba rabdosiae, 3 to 5 parts of indigo naturalis, 5 to 8 parts of radix sophorae tonkinensis, 2 to 4 parts of radix platycodonis, 2 to 4 parts of cortex moutan, 6 to 10 parts of radix astragali, 6 to 8 parts of radix pseudostellariae, 1 to 3 parts of ganoderma, 5 to 8 parts of donkey-hide gelatin, 2 to 4 parts of rhizoma imperatae, 2 to 4 parts of corn stigma, 2 to 4 parts of herba abri, 2 to 3 parts of ossa draconis, 2 to 3 parts of herba lysimachiae, 2 to 3 parts of semen plantaginis, 2 to 3 parts of chingma abutilon seed, 2 to 4 parts of medulla junci, 1 to 3 parts of myrmeleontid larva and 2 to 4 parts of pollen typhae. According to the theories that traditional Chinese medicines have efficacies of strengthening and consolidating body resistance and promoting blood circulation to remove blood stasis, the compound medicine has the effects of tonifying the liver and kidney, reinforcing Qi and nourishing Yin, clearing away heat and toxic materials, and dissolving and relieving swelling, can be used for treating the gastroenteric tumor, treats both manifestation and root cause of disease, and is good in curative effect and quick in result.

The invention relates to a method for producing a feed additive, particularly relates to a processing method of a feed additive and belongs to the technical field of feed processing. The method comprises the following steps of: performing solid mixing, fermentation, drying to obtain a finished product and other steps on grain stillage, bran and water, and transforming the grain stillage to a livestock feed additive with a high additional value by microbial fermentation. The additive can not only supplement feed resources which are in short supply, improve the utilization rate of feed and reduce the defecation amount of livestock and poultry, but also partially or totally replace the use of antibiotics and solve the problem of residues of the antibiotics in meat products, so that the additive solves the problem of treatment of wastes from a distillery and further solves the problem of short supply of the feed resources in livestock industry.

The invention belongs to the technical field of traditional Chinese medicines and in particular relates to a traditional Chinese medicine formula for treating gastrointestinal cancer. The traditional Chinese medicine formula is prepared from the following medicinal raw materials in parts by weight: 8-10 parts of radix pseudostellariae, 8-10 parts of mythic fungus, 8-10 parts of donkey hide gelatin, 8-10 parts of cortex albiziae, 5-8 parts of radix trichosanthis, 5-8 parts of prunella vulgaris, 3-5 parts of cassia seed, 2-4 parts of common lophantherum herb, 2-4 parts of baikal skullcap root, 2-4 parts of cortex Phellodendri, 2-4 parts of fructus forsythia, 2-4 parts of dandelion, 5-8 parts of herba violae, 3-5 parts of rhizoma smilacis glabrae, 3-5 parts of Chinese lobelia herb, 10-13 parts of pseudobulbus cremastrae seu pleiones, 5-8 parts of uniflower swisscentaury root, 3-5 parts of oldenlandia diffusa, 3-5 parts of dahurian patrinia herb, 3-5 parts of Chinese dwarf cherry seed, 2-3 parts of allium macrostemon, 5-8 parts of circium japonicum, 1-2 parts of large blister beetle, 3-5 parts of algae and 3-5 parts of kelp. By virtue of nursing of herbal treatment, the traditional Chinese medicine formula is capable of strengthening and consolidating body, promoting blood circulation, removing blood stasis, clearing away heat and toxic materials, activating blood to promote menstruation, eliminating swelling, removing stasis, and nourishing qi and yin and is fast in effect and good in curative effect of treating the gastrointestinal cancer.

The invention discloses an application of puerarin for preventing, treating and / or relieving irritable bowel syndrome. The puerarin can restore retarded cell cycles and promote the proliferation of intestinal epithelial cells by up-regulating the level of phosphorylated extracellular regulatory protein kinase (p-ERK). The puerarin can participate in the repair of the intestinal epithelial barrier by up-regulating expression of tight junction protein (occulting), and inhibit the hyperfunction of the hypothalamic-pituitary-adrenal axis (HPA axis) by down-regulating expression of hypothalamic corticotropin release factor (CRF1) receptor protein, and improve the gastrointestinal motility and visceral hypersensitivity. Tests prove that puerarin has a remarkable curative effect on the irritable bowel syndrome, takes effect quickly and has small side effects. The puerarin is an efficient, safe, stable medicine with extensive sources for treating the irritable bowel syndrome. The puerarin of the invention provides a new medicine source for preventing and treating the irritable bowel syndrome and complications thereof.